1. Home
  2. ENOV

as 09-04-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Industrials

Fluid Controls

Nasdaq

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Founded: 1995 Country:
United States
United States
Employees: N/A City: WILMINGTON
Market Cap: 1.6B IPO Year: 2008
Target Price: $51.00 AVG Volume (30 days): 1.1M
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -14.68 EPS Growth: N/A
52 Week Low/High: $25.46 - $49.83 Next Earning Date: 08-07-2025
Revenue: $2,189,576,000 Revenue Growth: 14.40%
Revenue Growth (this year): 9.13% Revenue Growth (next year): 6.39%

ENOV Daily Stock ML Predictions

Stock Insider Trading Activity of Enovis Corporation (ENOV)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Tandy Bradley J ENOV SVP and Chief Legal Officer Aug 22 '25 Buy $31.41 3,200 $100,512.00 43,515
BERRY PHILLIP BENJAMIN (BEN) ENOV SVP, Chief Financial Officer Aug 20 '25 Buy $29.71 2,500 $74,275.00 116,729
PRYOR DANIEL A ENOV EVP, Strategy & Business Dev. Aug 13 '25 Buy $28.90 10,000 $289,000.00 161,115

Share on Social Networks: